Biotech

All Articles

Basilea scores $268M BARDA funding for antifungals, anti-biotics

.Basilea Pharmaceutica's work developing brand new antifungals has actually acquired a significant i...

Capricor markets Europe civil rights to late-stage DMD treatment for $35M

.Possessing presently gathered up the U.S. rights to Capricor Therapies' late-stage Duchenne muscle ...

FDA junks adcomm for Applied's rare illness medicine

.After pushing the choice date for Applied Rehabs' metabolic condition drug govorestat, the FDA has ...

Novo inks $600M NanoVation bargain to examine hereditary medicines ex-liver

.Novo Nordisk is continuing its own press right into genetic medications, accepting pay NanoVation T...

Innovent links cytokine to colorectal cancer actions

.Innovent Biologics has produced the scenario that its checkpoint inhibitor-cytokine combination pro...

Merck, Daiichi ADC strikes goal in period 3 lung cancer cells research

.A stage 3 trial of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugate...

Rakovina grows AI focus along with collab to decide on cancer intendeds

.5 months after Rakovina Therapies pivoted toward artificial intelligence, the cancer-focused biotec...

Ascendis' dwarfism medicine favorites in phase 3, threatens BioMarin

.Ascendis Pharma has become a prospective danger to BioMarin's Voxzogo, stating period 3 growth ailm...

Despite ph. 3 miss out on, Alkeus finds path ahead of time for eye condition possession

.Though Alkeus Pharmaceuticals' oral eye condition asset failed to dramatically lessen geographical ...

Kairos goes social along with $6M IPO to money tests of cancer cells drug

.Along with a trio of biotechs reaching the Nasdaq on Friday, it was actually very easy to miss out ...